TDAY Q1 2026 Earnings Profitability Surprise as EPS Beats Estimates Stock Flat PFXNZ Q1 2026 Earnings Strong EPS Beat Driven by Solid Investment Income TEAD Q1 2026 Earnings Narrowed Loss Beats Expectations as Cost Discipline Shines PLAG Q3 2023 Earnings Narrowing Losses Amidst Strategic Reorientation NervGen Pharma Q3 2025 Earnings Narrowed Loss Meets Estimates But Stock Plunges 43 WW Q1 2026 Earnings WiderThanExpected Loss as Stock Rises Amid Strategic Uncertainty